Propranolol Administration Timing

Primary Recommendation

The American Academy of Pediatrics provides a strong recommendation (Grade X) that propranolol be administered with or after feeding to reduce the risk of hypoglycemia in pediatric patients, particularly infants and children 1, 2
Administer propranolol with or immediately after meals/feedings to prevent hypoglycemia, as recommended by the American Academy of Pediatrics 1, 2
Hold doses during times of diminished oral intake or vomiting to minimize the risk of hypoglycemia, as suggested by the American Academy of Pediatrics 1, 2
Avoid prolonged fasting intervals (>6 hours between feedings in infants) to reduce the risk of hypoglycemia, as recommended by the American Academy of Pediatrics 3, 4

Beta-blockade impairs glycogenolysis and gluconeogenesis, making patients vulnerable to hypoglycemia during fasting states, according to the American Academy of Pediatrics 1, 2
Early hypoglycemic symptoms (sweating, tachycardia, shakiness) may be masked by beta-blockade, allowing progression to neuroglycopenia with lethargy, seizures, or loss of consciousness, as noted by the American Academy of Pediatrics 1

Instruct patients to take propranolol with or immediately after meals to prevent hypoglycemia, as recommended by the American Academy of Pediatrics 1, 2
Hold doses during acute illness with reduced oral intake, vomiting, or diarrhea to minimize the risk of hypoglycemia, according to the American Academy of Pediatrics 1
Monitor for hypoglycemia symptoms, especially in infants and children, as suggested by the American Academy of Pediatrics 1, 2
Ensure regular feeding schedules without prolonged fasting for high-risk patients, such as infants, diabetics, or those with hepatic disease, as recommended by the American Academy of Pediatrics 3, 4
Educate caregivers about masked hypoglycemia symptoms in high-risk patients, according to the American Academy of Pediatrics 1

The British Journal of Dermatology recommends holding propranolol in cases of significantly reduced oral intake, vomiting, wheezing requiring treatment, hypotension, bradycardia, and before major surgery in certain patients 5
The American Academy of Pediatrics recommends holding propranolol in patients with sinus bradycardia, hypotension, heart block greater than first-degree, heart failure, or cardiogenic shock 6

The European Society of Cardiology recommends continuing beta-blockers when prescribed for ischemic heart disease or arrhythmias in patients undergoing non-cardiac surgery 7
The European Society of Cardiology recommends deferring non-cardiac surgery in patients with decompensated heart failure until they can be performed under optimal medical therapy in a stable condition 7

The British Journal of Dermatology recommends holding propranolol doses during episodes of significantly reduced oral intake, vomiting, or diarrhea in infants receiving propranolol for infantile hemangioma treatment 5
The American Academy of Pediatrics recommends holding propranolol doses during any acute illness interfering with normal oral intake in infants receiving propranolol for infantile hemangioma treatment 6

The British Journal of Dermatology reports that abrupt discontinuation of propranolol may lead to rebound tachycardia 5

The European Society of Cardiology recommends not withdrawing propranolol in patients treated for stable heart failure due to left ventricular systolic dysfunction 7
The British Journal of Dermatology reports that premature cessation of propranolol may lead to rebound growth of the hemangioma in patients with infantile hemangioma 5